The Sackler family, which are the owners of Purdue Pharma, could be forced to return billions of dollars if Arizona’s AG succeeds in getting their case heard by the Supreme Court.
Opioid Case Could Go To Supreme Court
Arizona Seeks For Purdue Pharma Owners To Return Billions
By ANITA SNOW and GEOFF MULVIHILL Associated Press
PHOENIX (AP) — Arizona's attorney general on Wednesday asked the U.S. Supreme Court to force the Sackler family, which owns OxyContin-maker Purdue Pharma, to return billions of dollars they took out of the company.
The court filing marks the first time the high court has been asked to weigh in directly on the nation's opioid crisis.
Arizona Attorney General Mark Brnovich said the filing is meant to ensure that Purdue has enough money to pay any future judgments or settlements. Nearly all other opioid-related cases brought by states, including a separate one filed last year by Arizona, are in state courts.
"We need to do everything we can to stop the opioid manufacturers from profiting from this crisis," Brnovich said in an interview. "They have siphoned off billions of dollars from the company, and I want to make sure that any money will end up with states and victims of the crisis — not in an account in the Cayman Islands or a Swiss bank."
A spokesman for the Sackler family said they deny the allegations in the claim. Brandon Messina said Arizona's claims are "inconsistent with the factual record."
The filing is the latest maneuver from a state seeking to hold the drug industry accountable for a crisis that costs more American lives each year than vehicle crashes.
"It's a power play," Abbe Gluck, a law professor at Yale Law School, said of Arizona's filing with the Supreme Court.
She said a ruling by the high court on the opioid issue, although a longshot, would have national impact.
Attorney Travis Lenkner, managing partner at a Chicago law firm representing Arizona in the Supreme Court case, said there were concerns that Sackler family members were sending some of the money abroad.
With sales down and legal liabilities looming, Purdue Pharma said earlier this year that it was considering filing for bankruptcy protection — potentially complicating the opioids lawsuits.
"This sort of seems like an end-run around the bankruptcy process," said Elizabeth Burch, a University of Georgia law professor who is following the opioid litigation.
Most U.S. states have sued Purdue over the toll of the national opioid crisis. At least 17 of them have now named members of the Sackler family, which owns the Stamford, Connecticut-based drug company.
The family includes major philanthropists who have given to museums and universities around the world. Some institutions, including New York's Metropolitan Museum of Art, have announced this year that they will no longer accept money from the family.
Some 2,000 local and tribal governments have sued Purdue and other companies that make and distribute drugs. Most of those cases are in federal court and are overseen by a judge in Cleveland. Judge Dan Polster is pushing the parties to negotiate a settlement but also has scheduled the first trial for October.
The negotiations are being conducted in secret, but there are signs of animosity between local and state governments over control of any money the settlements would generate.
Opioids, a class of drugs that includes prescription medications such as OxyContin and Percocet and illicit drugs including heroin and fentanyl, have been blamed for more than 400,000 deaths in the U.S. since 2000. The drugs were linked to more than 47,000 deaths in both 2017 and 2018 — more than auto accidents.
Arizona's lawsuit alleges that the family has pulled "billions of dollars out of the company in recent years. The law does not permit the Sacklers to reap a windfall while Purdue's creditors absorb a massive loss."
The filing notes that the U.S. Constitution allows the Supreme Court to have jurisdiction over controversies between a state and citizens of another state.
In addition to bringing our readers stories about education issues in America, we here at Hispanic Outlook feature news articles on topics both related to and outside of the field of education on our website and in our social media.
Hispanic Outlook is an education magazine in the US available both in print and digital form. Visit https://www.hispanicoutlook.com/education-magazine for information about our latest issue, including our new supplement Physician Outlook.
Hispanic Outlook’s Job Board allows applicants to search for jobs by category, by city and by state. Both Featured and Latest Job Positions are available at https://hispanicoutlookjobs.com/
And for employers, Hispanic Outlook’s Job Board offers a wide variety of posting options. Further information is available at https://hispanicoutlookjobs.com/employer-products/
Other articles from Hispanic Outlook:
More States Sue Opioid Maker
SACRAMENTO, Calif. (AP) — California, Hawaii, Maine and the District of Columbia filed lawsuits Monday against the maker of OxyContin and the company's former president, alleging the firm falsely promoted the drug by downplaying the risk of addiction while it emerged as one of the most widely abused opioids in the U.S.
The lawsuits were the latest by states and local governments against drugmaker Purdue Pharma as the country grapples with an opioid epidemic. About a dozen states have also targeted Richard Sackler, the company's former leader, or members of his family. "Purdue and the Sacklers traded the health and well-being of Californians for profit and created an unprecedented national public health crisis in the process," California Attorney General Xavier Becerra said at a news conference announcing the legal action by...
Read full article here
Controversial Opioid Guidelines
The World Health Organization notified U.S. lawmakers last month that it will discontinue two publications on prescribing opioid painkillers in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines comes a month after U.S. Reps. Katherine Clark and Hal Rogers accused the WHO of being influenced by Purdue Pharma, the American manufacturer of the potent painkiller OxyContin. The lawmakers report claimed the guidelines, crafted in part by organizations with financial ties to the company, downplay the risk of opioids despite the American epidemic that has killed more than 390,000 since 1999. WHOs reports are viewed around the world as best practices in public health policy, and the opioid prescribing documents have been in circulation for years. “That is a very dangerous…
Read full article here
Marijuana And The Opioid Crisis
Legalizing medical marijuana does not reduce the rate of fatal opioid overdoses, according to researchers at the Stanford University School of Medicine. The finding contradicts a 2014 study that legal-pot advocates, public officials and even physicians have touted as a reason to legalize marijuana. That study found lower rates of fatal opioid overdoses in the states that had legalized marijuana for medical purposes than in states where marijuana remained illegal. The Stanford study, which revisited the issue after many more states had legalized medical marijuana, found no evidence of a connection between opioid deaths and the availability of medical cannabis, said Keith Humphreys, Ph.D., professor of psychiatry and behavioral sciences. “If you think opening a bunch of dispensaries is going to reduce opioid deaths, you’ll be…
Read full article here
